^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    IO-202

    i
    Company:
    Immune-Onc Therap
    Drug class:
    ILT-3 inhibitor
    Related drugs: